Primary cancer-associated fibroblasts isolated from fresh NSCLC tumor tissue and cryopreserved at early passage. Identity confirmed by FAP, α-SMA and vimentin. For fibrosis, tumor microenvironment and drug-response studies. Research use only.
$1,680
| Tumor type | Non-Small Cell Lung Cancer (adenocarcinoma, squamous cell carcinoma) |
| Species | Homo sapiens, human |
| Tissue source | Tumor tissue |
| Post-thaw viability (guaranteed min %) | > 80% |
| Cells per vial | > 1 x 10^6 cells |
| Freezing medium | CryoStor/FBS+DMSO |
| Medium kit available? | Yes |
| Storage on arrival | LN Vapor |
| Ships as | Vials on dry ice |
| Biosafety level | BSL-2 |
| Donor clinical metadata provided | Yes |
| Marker panel | Biomarker-authenticated |
| Mycoplasma test | Yes |
| Certificate of Analysis (CoA) | Included |
| Intended use | This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. |
| Consent covers commercial sale of derived cells? | Yes – IRB-approved |
